Drug Type siRNA |
Synonyms |
Target |
Mechanism APOC3 inhibitors(Apolipoprotein C-III inhibitors), TMPRSS6 inhibitors(Transmembrane protease serine 6 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemochromatosis | Preclinical | US | 10 Nov 2023 | |
Hypertriglyceridemia | Preclinical | US | 10 Nov 2023 |